Pyramid Laboratories, Inc.

Pyramid Laboratories provides end-to-end contract development and manufacturing services for cell therapies and large-molecule therapeutics. The company offers formulation development, analytical testing, stability studies, aseptic fill-finish manufacturing—including vial and syringe filling—and lyophilization. It operates a cGMP-compliant facility in Orange County, California that has recently expanded to increase capacity for both vials and syringes. The firm has over three decades of experience serving pharmaceutical and biotech clients.

As a CDMO, it does not have its own clinical results or proprietary drug pipeline but supports the clinical/commercial programs of its clients.

No specific clinical results or internal drug candidates are reported.

Pipeline_breadth/pipeline fields are not applicable to this business model.

The company appears to be independently operated as of June 2025.

Key people include an experienced team with long tenure in pharma/biotech analytics/manufacturing.[1]

Its location in Orange County places it within a major West Coast life sciences hub.[1]

In April 2023 Audax Private Equity listed the company among its portfolio companies but there’s no clear evidence that it was acquired outright by Audax.[2]